Innova Captab Ltd (INNOVACAP)
₹950.45
Mkt cap
₹5,439 Cr
P/E ratio
38.80
P/B
4.98
Div yield
0.21%
ROE
13.70%
ROCE
15.00%
EPS (TTM)
₹24.50
Book value
₹191
52W range
645–1,011
Sector
Healthcare
Incorporated in January 2005, Innova Captab Ltd is a pharmaceutical company is an integrated pharmaceutical company in India with a presence across the pharmaceutical value chain. [1]
Health check
Constructive
ValuationFair
ProfitabilityAverage
GrowthHigh
TechnicalsBullish
52-week range
−6.02% from high₹950
₹645+47.41% from low₹1,011
Current
₹950.45
Prev close
₹947.00
Day
+0.36%
Price performance
1D
+0.36%
1W
−2.34%
1M
+0.97%
3M
+31.80%
6M
+45.61%
1Y
+2.49%
YTD
+31.07%
Financials
FRevenue, profit & margin
P/E ratio
38.8×
INNOVACAP is 14% above the sector median of 34.0×
INNOVACAP38.8×
Sector median34.0×
| Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Trend | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 241 | 233 | 283 | 302 | 263 | 294 | 318 | 316 | 315 | 352 | 380 | 450 | 448 | |
| Expenses | 214 | 202 | 242 | 258 | 225 | 252 | 268 | 270 | 267 | 299 | 329 | 381 | 383 | |
| Operating Profit | 27 | 31 | 40 | 45 | 38 | 42 | 50 | 47 | 48 | 52 | 52 | 69 | 65 | |
| OPM % | 11% | 13% | 14% | 15% | 14% | 14% | 16% | 15% | 15% | 15% | 14% | 15% | 15% | |
| Other Income | 3 | 1 | 3 | 2 | 6 | 2 | 2 | 4 | 3 | 4 | 4 | 2 | 2 | |
| Interest | 5 | 5 | 9 | 7 | 1 | 0 | 0 | 0 | 2 | 3 | 6 | 4 | 5 | |
| Depreciation | 3 | 3 | 5 | 5 | 3 | 5 | 5 | 5 | 10 | 11 | 11 | 11 | 11 | |
| Profit before tax | 21 | 25 | 30 | 35 | 40 | 39 | 47 | 46 | 39 | 43 | 39 | 56 | 51 | |
| Tax % | 19% | 28% | 24% | 29% | 27% | 25% | 25% | 25% | 25% | 27% | 24% | 24% | 25% | |
| Net Profit | 17 | 18 | 23 | 25 | 29 | 29 | 35 | 34 | 30 | 31 | 30 | 42 | 38 | |
| EPS in Rs | 3.59 | 3.66 | 4.77 | 4.39 | 5.02 | 5.15 | 6.12 | 5.98 | 5.17 | 5.42 | 5.18 | 7.37 | 6.65 | |
| Raw PDF |
Earnings
EResults dates & reactionsNo upcoming results date on calendar.
Fresh quarters land in the Financials table above, tagged NSE until screener catches up.
No reaction history yet.
No quarterly filings ingested yet.
Corporate actions
CLast 6 monthsNo recent corporate actions
Dividends, splits, and bonuses in the last six months show up here.
Shareholding
Sas of Jun 202650.90%Promoter
Promoters50.90%
FIIs0.34%0.11
DIIs19.92%0.22
Public28.84%0.10
Ownership trend
Peers
P8 companiesValuation vs quality
P/E × ROCE · bubble = market cap| Name | CMP | P/E | Mkt Cap | Div Yld | NP Qtr | Qtr Profit Var | Sales Qtr | Qtr Sales Var | ROCE |
|---|---|---|---|---|---|---|---|---|---|
| Sun Pharma.Inds. | ₹1,941.10 | 37.48 | 4,65,735 | 0.82% | 2,710 | +13.58% | 14,612 | +12.76% | 20.53% |
| Divi's Lab. | ₹7,248.50 | 73.36 | 1,92,425 | 0.41% | 751 | +13.44% | 2,831 | +9.52% | 21.97% |
| Torrent Pharma. | ₹4,961.50 | 86.11 | 1,88,720 | 0.77% | 364 | −20.58% | 4,197 | +41.84% | 15.19% |
| Cipla | ₹1,410.60 | 31.84 | 1,13,955 | 0.92% | 786 | −39.19% | 7,119 | +2.33% | 15.49% |
| Zydus Lifesci. | ₹1,108.70 | 20.38 | 1,10,593 | 0.09% | 1,341 | +21.92% | 7,587 | +16.22% | 21.14% |
| Lupin | ₹2,370.50 | 19.06 | 1,08,387 | 0.76% | 1,469 | +101.49% | 7,475 | +31.89% | 29.93% |
| Mankind Pharma | ₹2,507.20 | 51.44 | 1,03,546 | 0.04% | 559 | +34.23% | 3,443 | +11.81% | 13.53% |
| Innova Captab | ₹950.45 | 38.75 | 5,439 | 0.21% | 38 | +28.78% | 448 | +42.28% | 14.96% |
| Median: 157 Co. | ₹432.05 | 34.03 | 1,978 | 0.10% | 15 | +28.10% | 176 | +17.66% | 15.10% |
Filings
DConcall transcripts30
TranscriptMay 2026PPTMay 2026RECMay 2026TranscriptFeb 2026TranscriptFeb 2026PPTFeb 2026RECFeb 2026TranscriptNov 2025PPTNov 2025RECNov 2025TranscriptAug 2025PPTAug 2025RECAug 2025TranscriptMay 2025PPTMay 2025RECMay 2025TranscriptFeb 2025PPTFeb 2025RECFeb 2025TranscriptNov 2024PPTNov 2024RECNov 2024TranscriptAug 2024PPTAug 2024
Credit ratings6
Announcements5
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 3 Jul - Submitted Regulation 74(5) certificate for quarter ended 30 June 2026; no dematerialization requests received.Announcement under Regulation 30 (LODR)-Newspaper Publication 25 Jun - Pursuant to the regulation 30 read with schedule III, Part A, Para A of SEBI LODR Regulations, 2015, as amended, we are enclosing herewith copies …Closure of Trading Window 25 Jun - Trading window closed1 July 2026 until 48 hours after Q1 FY2027 results.Intimation Of Postponement Of The 22Nd Annual General Meeting Of The Company 24 Jun - Innova Captab postpones its 22nd AGM scheduled for 29 June 2026.Announcement under Regulation 30 (LODR)-Newspaper Publication 6 Jun - Pursuant to regulation 30 read with schedule III Part A Para A and Regulation 47 of SEBI (LODR) 2015 as amended time to time and …